Founded by scientists and healthcare professionals with experience at Procter & Gamble and McKesson, Noxsano is a wound-care company developing treatments for veterinary and human medicine. Its patented technology delivers nitric oxide at the wound site, with veterinary use serving as the company’s initial market before planned expansion into human care.